ArticleFrontiers in medicine2024
Nomogram-based prediction of the risk of AVF maturation: a retrospective study.
Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An interpretable XGBoost model for predicting arteriovenous fistula dysfunction in end stage renal disease.Frontiers in surgery · 2026Article
- Preoperative Doppler Ultrasound Parameters as Predictors of Arteriovenous Fistula Maturation in End-Stage Renal Disease: A Prospective Cohort Study.International journal of nephrology and renovascular disease · 2026Article
- Establishment and Evaluation of Nomogram Model for Predicting the Risk of Arteriovenous Fistula Dysfunction in Patients Undergoing MHD.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Early identification of autogenous arteriovenous fistula (AVF) maturation failure in patients with end-stage renal disease (ESRD) is crucial, as it enables early interventions that can enhance AVF maturation rates and reduce the duration of catheter use. This study aimed to identify factors that may predict arteriovenous fistula maturation in patients undergoing maintenance hemodialysis. Methods: This retrospective study included a cohort of 532 ESRD patients who underwent AVF creation and routine follow-up at the Beijing Haidian Hospital (Haidian Section of Pecking University Third Hospital) from August 2018 to March 2022. A total of 532 patients were randomly divided into a training cohort (389 cases) and a validation cohort (143 cases). Patients in each cohort were categorized into mature and non-mature groups based on whether they met clinical or ultrasound criteria 3 months after AVF creation. The timing of early intervention for non-maturation AVF was preliminarily discussed after a risk prediction nomogram for non-maturation in newly AVF creation was constructed. Results: Of the 532 patients, 379 (73.24%) achieved fistula maturation at 3 months postoperatively. We randomly divided the total study population using computer-generated randomization into a training cohort ( Conclusion: The anastomotic diameter (anas1), the internal diameter of the anastomotic vein (V1), brachial artery blood flow (F1) at 1 month, and brachial artery blood flow (F3) at 3 months postoperatively can predict the unassisted maturation of AVF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.